9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
AstraZeneca
Eli Lilly and Company
Aminex Therapeutics, Inc.
Nuvation Bio Inc.
BBB-Therapeutics B.V.
INSYS Therapeutics Inc
Envita Medical Center, Inc.
TransMolecular
Thallion Pharmaceuticals